There is more regulatory interest in ambient products and growing opportunities for solution providers to enter this market. In this presentation Ian Holloway, Manager, Defective Medicines Report Centre, Medicines and Healthcare Products Regulatory Agency (MHRA), discusses the expectations and documenting for ambient or CRT products, regulatory expectations for qualification or validation and stability studies versus shipping studies.
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Steigenberger Airport Hotel Berlin, Deutschland
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1, 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit
1 - 3 December, 2026
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More